Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,410.37
(
0.13%
)
US TECH 100
28,424.80
(
0.48%
)
Dow Jones
49,471.16
(
-0.58%
)
Brent Oil
105.06
(
-0.67%
)
Bitcoin
79,300.02
(
-1.48%
)
News Focus
News Focus

Replies to post #5620 on Talon Therapeutics Inc (fka TLON)

Replies to #5620 on Talon Therapeutics Inc (fka TLON)
icon url

bmatt

05/29/13 12:43 PM

#5621 RE: dudoro80 #5620

Can anyone explain how Talon could end enrollment at 27 when the target number was 40 for the Menadione Phase II trial? Especially since is was double blinded.